John Christopher Evans, MD
Cardiac Electrophysiology · Alameda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 3
Offices
3 locations · Alameda Health System · 597 clinicians in this group
Hospitals listed: Alameda Hospital · Highland Hospital. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Evans’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A108412 · Current
Licensed to practise in California · since 2009 · expires 2027-05-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alameda HospitalAlameda, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Alameda Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.12) · 119 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.45 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.3 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 210 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 532 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 1,916 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.77 to 5.96) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.3 (0.58 to 4.02) · 85 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 1.23) · 1,359 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -2.4 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -3.6 · 242 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 40 cases | None | Jul 2023 – Jun 2025 |
What patients said (319 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$19,876
Medicare paid this office $19,876 for 252 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,794 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,926 | $154 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 40 | $1,252 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,157 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $942 | $7 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,794 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $2,926 | $154 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 40 | $1,252 | $28 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,157 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $942 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 29 | $513 | $17 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $226 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 14 | $146 | $10 |
Procedures Medicare counted
| Pacemaker insertion or repair | 37 | More than 83% of doctors who do this |
Who their Medicare patients are
252 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 14% · Women 48% · Also on Medicaid 87% · Health risk score 2.30. Sicker patients than 9 in 10 peers; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Diabetes 49% · Heart failure 46% · Chronic kidney disease 41% · Atrial fibrillation 38% · Coronary heart disease 33% · COPD 27% · Depression 22% · Stroke 19% · Dementia 17% · Cancer 10%.
The office billed $117,337, Medicare allowed $25,695 and paid $19,876; for 370 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 252 | 370 | 73 | 2.30 | $117,337 | $19,876 |
| 2023 | 75 | 123 | 74 | 1.94 | $115,551 | $19,323 |
| 2022 | 67 | 117 | 77 | 1.99 | $68,367 | $14,465 |
| 2021 | 111 | 229 | 75 | 2.08 | $171,782 | $33,666 |
| 2020 | 62 | 141 | 74 | 2.65 | $140,686 | $26,768 |
| 2019 | 35 | 70 | 76 | 1.95 | $63,997 | $11,764 |
| 2018 | 474 | 1,144 | 75 | 1.87 | $387,825 | $92,243 |
| 2017 | 1,100 | 3,049 | 75 | 1.73 | $947,520 | $247,228 |
| 2016 | 1,202 | 3,238 | 76 | 1.70 | $1,161,526 | $303,775 |
| 2015 | 1,111 | 2,980 | 76 | 1.82 | $1,164,544 | $299,793 |
| 2014 | 1,038 | 2,497 | 75 | 1.68 | $896,367 | $233,583 |
| 2013 | 827 | 2,000 | 76 | 1.63 | $859,418 | $226,339 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,468 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,181 | $110 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,382 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,838 | $118 |
| Hospital discharge day management, 30 minutes or less | 11 | $681 | $62 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,873 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $4,260 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,701 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,726 | $66 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,087 | $68 |
2020: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,394 | $189 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,443 | $98 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,664 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,083 | $68 |
2019: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,016 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $857 | $66 |
2018: 21 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $11,681 | $417 |
| Return visit (30+ min) | 118 | $9,371 | $66 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $9,367 | $852 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,268 | $161 |
| Programming of dual lead pacemaker system | 135 | $4,550 | $32 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 17 | $4,049 | $238 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,475 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 194 | $2,743 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $1,944 | $57 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $1,734 | $116 |
| Short return visit (20+ min) | 39 | $1,548 | $40 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 13 | $1,431 | $110 |
| Long return visit (40+ min) | 13 | $1,396 | $93 |
| Programming of dual lead implantable defibrillator system | 17 | $1,037 | $43 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $810 | $74 |
| Programming of single lead pacemaker system | 26 | $631 | $23 |
| Programming of multiple lead implantable defibrillator system | 13 | $548 | $39 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 49 | $475 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 30 | $214 | $6 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $194 | $15 |
| External ekg recording for more than 48 hours up to 21 days | 13 | $194 | $15 |
2017: 33 services
| Return visit (30+ min) | 272 | $32,636 | $78 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 54 | $22,621 | $419 |
| Programming of dual lead pacemaker system | 315 | $18,561 | $41 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $13,751 | $688 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $13,669 | $163 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 30 | $9,934 | $320 |
| Insertion of implantable defibrillator system | 13 | $9,715 | $747 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $9,603 | $873 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 437 | $9,031 | $13 |
| New patient visit (60+ min) | 56 | $8,950 | $160 |
| Programming of dual lead implantable defibrillator system | 67 | $6,123 | $60 |
| Short return visit (20+ min) | 105 | $6,044 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $6,033 | $84 |
| Long return visit (40+ min) | 47 | $5,281 | $104 |
| Insertion of pacemaker and lower heart chamber electrode | 13 | $5,133 | $395 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 97 | $4,647 | $48 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,638 | $386 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 11 | $4,005 | $334 |
| Programming of heart rhythm stimulation after drug infusion | 30 | $3,987 | $129 |
| Programming of multiple lead implantable defibrillator system | 41 | $3,602 | $63 |
| Programming of single lead pacemaker system | 77 | $3,218 | $36 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 20 | $2,372 | $113 |
| External shock to heart to regulate heart beat | 19 | $1,970 | $86 |
| New patient visit (45+ min) | 17 | $1,961 | $115 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 19 | $1,837 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,623 | $58 |
| Programming of single lead implantable defibrillator system | 26 | $1,402 | $42 |
| New patient visit (30+ min) | 15 | $1,159 | $77 |
| Programming of multiple lead pacemaker system | 11 | $821 | $51 |
| External ekg recording for more than 48 hours up to 21 days | 24 | $523 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $519 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 67 | $477 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $436 | $21 |
2016: 36 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 66 | $28,330 | $429 |
| Return visit (30+ min) | 218 | $24,969 | $79 |
| Programming of dual lead pacemaker system | 385 | $22,003 | $40 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 29 | $19,475 | $672 |
| Insertion of implantable defibrillator system | 25 | $19,165 | $767 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 18 | $16,801 | $933 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 48 | $15,322 | $319 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $15,251 | $161 |
| New patient visit (60+ min) | 72 | $11,658 | $162 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 388 | $8,265 | $13 |
| Long return visit (40+ min) | 62 | $7,050 | $108 |
| Insertion of pacemaker and lower heart chamber electrode | 17 | $6,834 | $402 |
| Programming of heart rhythm stimulation after drug infusion | 54 | $6,829 | $126 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 17 | $6,492 | $382 |
| Programming of dual lead implantable defibrillator system | 72 | $6,200 | $59 |
| Programming of single lead pacemaker system | 120 | $5,735 | $36 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 46 | $5,544 | $83 |
| Short return visit (20+ min) | 99 | $5,393 | $52 |
| Programming of multiple lead implantable defibrillator system | 49 | $4,704 | $62 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $4,702 | $336 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $4,319 | $50 |
| External shock to heart to regulate heart beat | 29 | $3,382 | $99 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 35 | $3,154 | $90 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $2,705 | $113 |
| New patient visit (45+ min) | 14 | $1,867 | $133 |
| Implantation patient-activated heart monitoring device | 11 | $1,836 | $167 |
| New patient visit (60+ min) | 11 | $1,380 | $125 |
| Programming of single lead implantable defibrillator system | 18 | $1,372 | $47 |
| New patient visit (30+ min) | 15 | $1,199 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,158 | $58 |
| Programming of multiple lead pacemaker system | 12 | $831 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $765 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 71 | $547 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $458 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 22 | $442 | $17 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 14 | $438 | $27 |
2015: 37 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 76 | $32,338 | $426 |
| Insertion of implantable defibrillator system | 31 | $23,404 | $755 |
| Return visit (30+ min) | 189 | $22,537 | $82 |
| Programming of dual lead pacemaker system | 329 | $21,723 | $44 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 17 | $17,775 | $936 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $14,711 | $163 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $13,384 | $669 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 36 | $12,108 | $319 |
| New patient visit (60+ min) | 54 | $8,460 | $157 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 21 | $8,098 | $386 |
| Long return visit (40+ min) | 63 | $7,899 | $108 |
| Insertion of pacemaker and lower heart chamber electrode | 18 | $7,119 | $395 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | $6,902 | $13 |
| Programming of dual lead implantable defibrillator system | 72 | $6,683 | $61 |
| Programming of multiple lead implantable defibrillator system | 58 | $6,266 | $69 |
| Programming of heart rhythm stimulation after drug infusion | 42 | $5,878 | $131 |
| Short return visit (20+ min) | 96 | $5,821 | $53 |
| Programming of single lead pacemaker system | 93 | $4,485 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $4,291 | $49 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,219 | $293 |
| External shock to heart to regulate heart beat | 22 | $2,818 | $97 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 22 | $2,722 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,266 | $84 |
| New patient visit (45+ min) | 17 | $2,179 | $128 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 21 | $2,057 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,990 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $1,864 | $58 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 26 | $1,605 | $42 |
| Programming of single lead implantable defibrillator system | 26 | $1,589 | $47 |
| New patient visit (30+ min) | 15 | $1,230 | $82 |
| Removal of permanent pacemaker pulse generator | 11 | $1,136 | $103 |
| Long return visit (40+ min) | 12 | $1,076 | $90 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 48 | $1,006 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $927 | $49 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 35 | $906 | $24 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $904 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 52 | $393 | $6 |
2014: 31 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 83 | $36,060 | $434 |
| Return visit (30+ min) | 185 | $21,193 | $80 |
| Insertion of implantable defibrillator system | 24 | $18,233 | $760 |
| Programming of dual lead pacemaker system | 283 | $17,252 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 91 | $15,363 | $163 |
| Long return visit (40+ min) | 88 | $11,454 | $109 |
| New patient visit (60+ min) | 62 | $9,932 | $160 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 20 | $7,703 | $385 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,556 | $687 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 20 | $6,822 | $325 |
| Insertion of pacemaker and lower heart chamber electrode | 17 | $6,413 | $377 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 301 | $5,815 | $13 |
| Programming of dual lead implantable defibrillator system | 52 | $4,598 | $61 |
| New patient visit (45+ min) | 32 | $4,207 | $131 |
| Short return visit (20+ min) | 64 | $3,669 | $55 |
| Programming of multiple lead implantable defibrillator system | 33 | $3,161 | $72 |
| Programming of single lead pacemaker system | 63 | $2,969 | $37 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $2,916 | $133 |
| External shock to heart to regulate heart beat | 22 | $2,411 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $2,337 | $49 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 13 | $1,910 | $147 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,887 | $111 |
| Programming of single lead implantable defibrillator system | 24 | $1,800 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,334 | $83 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 13 | $1,265 | $97 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 60 | $1,221 | $18 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 23 | $1,171 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $1,081 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $1,033 | $49 |
| Long return visit (40+ min) | 11 | $981 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 77 | $653 | $7 |
2013: 33 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 56 | $23,740 | $424 |
| Insertion of implantable defibrillator system | 26 | $19,307 | $743 |
| New patient visit (60+ min) | 115 | $18,401 | $160 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 26 | $17,471 | $672 |
| Long return visit (40+ min) | 107 | $15,195 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $14,872 | $157 |
| Return visit (30+ min) | 122 | $13,194 | $83 |
| Programming of dual lead pacemaker system | 184 | $9,833 | $42 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 22 | $8,251 | $375 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 26 | $8,205 | $316 |
| Removal and replacement of dual lead permanent pacemaker | 20 | $6,018 | $301 |
| Insertion of pacemaker and lower heart chamber electrode | 14 | $5,195 | $371 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 157 | $3,597 | $15 |
| Programming of dual lead implantable defibrillator system | 43 | $3,295 | $60 |
| Programming of multiple lead implantable defibrillator system | 34 | $3,151 | $68 |
| Programming of single lead pacemaker system | 60 | $2,760 | $38 |
| Programming of heart rhythm stimulation after drug infusion | 21 | $2,700 | $129 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,318 | $80 |
| New patient visit (45+ min) | 19 | $2,291 | $121 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 23 | $2,173 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,162 | $48 |
| Short return visit (20+ min) | 35 | $2,148 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,964 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 69 | $1,533 | $18 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 32 | $1,346 | $37 |
| Programming of single lead implantable defibrillator system | 22 | $1,327 | $47 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | $1,312 | $23 |
| External shock to heart to regulate heart beat | 14 | $1,276 | $91 |
| Removal of permanent pacemaker pulse generator | 12 | $1,186 | $99 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 25 | $1,123 | $40 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $862 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $787 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $680 | $57 |
Medicaid work
$28,220 in 2024
Medicaid paid $28,220 for 878 billed services this clinician did in 2024, up to 177 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 171 | $23,674 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 429 | $2,184 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous implantable defibrillator system, including analysis of heart rhythm derived data elements | 58 | $1,145 |
| Long return visit (40+ min) | 93 | $801 |
| Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead pacemaker system, or leadless pacemaker system | 17 | $326 |
| Return visit (30+ min) | 76 | $91 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; scanning analysis with report | 22 | $0 |
| Prolonged outpatient evaluation and management service(s) time with or without direct patient contact beyond the required time of the primary service when the primary service level has been selected using total time, each 15 minutes of total time (List separately in addition to the code of the outpatient Evaluation and Management service) | 12 | $0 |
| 2024 | 878 | 8 | 177 | $28,220 |
Drugs they prescribed that Part D paid
$9,481
Pharmacies billed $9,481 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 56) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
48 generic and fewer than 11 brand-name prescriptions · $9,481 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Metoprolol | 12 | $183 | $15 |
Year by year
| 2024 | 56 | 24 | 0% (0) | None | $9,481 |
| 2019 | 55 | 34 | 0% (0) | 47% | $19,014 |
| 2018 | 1,817 | 309 | 0% (0) | 26% | $349,674 |
| 2017 | 3,100 | 385 | None | 24% | $432,652 |
| 2016 | 2,786 | 388 | None | None | $299,433 |
| 2015 | 2,476 | 356 | None | 23% | $246,832 |
| 2014 | 2,320 | 307 | None | None | $174,592 |
| 2013 | 1,700 | 248 | 0% (0) | 16% | $86,189 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Eliquis | 12 | $7,994 | $666 |
2018: 27 drugs
| Eliquis | 190 | $126,972 | $668 |
| Xarelto | 118 | $92,192 | $781 |
| Dofetilide | 92 | $43,451 | $472 |
| Pradaxa | 17 | $14,504 | $853 |
| Flecainide Acetate | 74 | $5,272 | $71 |
| Corlanor | 11 | $4,710 | $428 |
| Metoprolol | 145 | $4,516 | $31 |
| Sotalol | 160 | $3,952 | $25 |
| Digoxin | 46 | $1,905 | $41 |
| Amiodarone | 45 | $1,727 | $38 |
| Potassium Chloride | 42 | $1,599 | $38 |
| Cartia Xt | 19 | $1,134 | $60 |
| Digox | 11 | $1,098 | $100 |
| Spironolactone-Hctz | 23 | $1,074 | $47 |
| Atorvastatin | 61 | $1,029 | $17 |
| Rosuvastatin | 26 | $1,028 | $40 |
| Metoprolol | 131 | $956 | $7 |
| Losartan | 86 | $859 | $10 |
| Carvedilol | 68 | $811 | $12 |
| Lisinopril | 85 | $690 | $8 |
| Furosemide | 56 | $380 | $7 |
| Spironolactone | 36 | $279 | $8 |
| Pravastatin | 12 | $262 | $22 |
| Amlodipine Besylate | 25 | $230 | $9 |
| Warfarin | 11 | $106 | $10 |
| Lisinopril-Hydrochlorothiazide | 14 | $99 | $7 |
| Simvastatin | 11 | $44 | $4 |
2017: 41 drugs
| Xarelto | 193 | $123,842 | $642 |
| Eliquis | 171 | $105,569 | $617 |
| Dofetilide | 152 | $77,611 | $511 |
| Pradaxa | 39 | $30,546 | $783 |
| Multaq | 15 | $17,955 | $1,197 |
| Flecainide Acetate | 98 | $8,060 | $82 |
| Metoprolol | 230 | $7,840 | $34 |
| Sotalol | 263 | $7,073 | $27 |
| Digoxin | 114 | $4,787 | $42 |
| Mexiletine | 19 | $3,176 | $167 |
| Potassium Chloride | 77 | $2,498 | $32 |
| Atorvastatin | 125 | $1,710 | $14 |
| Carvedilol | 174 | $1,596 | $9 |
| Cartia Xt | 32 | $1,565 | $49 |
| Metoprolol | 228 | $1,497 | $7 |
| Rosuvastatin | 29 | $1,432 | $49 |
| Losartan | 122 | $1,241 | $10 |
| Lisinopril | 167 | $1,209 | $7 |
| Spironolactone-Hctz | 30 | $1,093 | $36 |
| Amiodarone | 58 | $1,031 | $18 |
| Chlorthalidone | 13 | $867 | $67 |
| Sotalol Af | 26 | $831 | $32 |
| Digox | 12 | $808 | $67 |
| Diltiazem 24hr Er | 13 | $715 | $55 |
| Amlodipine Besylate | 100 | $652 | $7 |
| Fenofibrate | 11 | $649 | $59 |
| Pravastatin | 28 | $604 | $22 |
| Furosemide | 103 | $588 | $6 |
| Hydralazine | 24 | $530 | $22 |
| Klor-Con M20 | 15 | $400 | $27 |
| Triamterene-Hydrochlorothiazid | 28 | $385 | $14 |
| Spironolactone | 51 | $356 | $7 |
| Bisoprolol | 13 | $318 | $24 |
| Doxycycline Hyclate | 15 | $271 | $18 |
| Clopidogrel | 13 | $244 | $19 |
| Warfarin | 19 | $187 | $10 |
| Atenolol | 20 | $176 | $9 |
| Simvastatin | 36 | $136 | $4 |
| Benazepril | 12 | $121 | $10 |
| Losartan-Hydrochlorothiazide | 14 | $77 | $5 |
| Lisinopril-Hydrochlorothiazide | 12 | $72 | $6 |
2016: 36 drugs
| Xarelto | 144 | $83,146 | $577 |
| Eliquis | 78 | $42,359 | $543 |
| Tikosyn | 43 | $37,896 | $881 |
| Pradaxa | 41 | $28,716 | $700 |
| Multaq | 28 | $25,353 | $905 |
| Dofetilide | 39 | $23,116 | $593 |
| Sotalol | 323 | $8,349 | $26 |
| Metoprolol | 184 | $5,831 | $32 |
| Flecainide Acetate | 111 | $5,752 | $52 |
| Crestor | 12 | $4,392 | $366 |
| Digoxin | 77 | $2,782 | $36 |
| Atorvastatin | 140 | $2,400 | $17 |
| Potassium Chloride | 92 | $2,217 | $24 |
| Carvedilol | 188 | $1,636 | $9 |
| Metoprolol | 191 | $1,115 | $6 |
| Chlorthalidone | 19 | $1,079 | $57 |
| Lisinopril | 185 | $952 | $5 |
| Digox | 24 | $906 | $38 |
| Pravastatin | 40 | $898 | $22 |
| Amiodarone | 54 | $872 | $16 |
| Losartan | 94 | $865 | $9 |
| Diltiazem 24hr Er | 13 | $735 | $57 |
| Sotalol Af | 17 | $720 | $42 |
| Valsartan | 25 | $655 | $26 |
| Amlodipine Besylate | 104 | $527 | $5 |
| Spironolactone | 64 | $524 | $8 |
| Spironolactone-Hctz | 14 | $350 | $25 |
| Furosemide | 68 | $342 | $5 |
| Clopidogrel | 18 | $318 | $18 |
| Triamterene-Hydrochlorothiazid | 27 | $315 | $12 |
| Nitrostat | 12 | $297 | $25 |
| Hydralazine | 11 | $290 | $26 |
| Enoxaparin | 13 | $281 | $22 |
| Simvastatin | 37 | $166 | $4 |
| Atenolol | 25 | $116 | $5 |
| Omeprazole | 15 | $115 | $8 |
2015: 35 drugs
| Xarelto | 132 | $68,226 | $517 |
| Tikosyn | 88 | $46,814 | $532 |
| Multaq | 42 | $27,518 | $655 |
| Pradaxa | 43 | $22,284 | $518 |
| Eliquis | 33 | $14,884 | $451 |
| Sotalol | 278 | $7,038 | $25 |
| Metoprolol | 143 | $6,055 | $42 |
| Flecainide Acetate | 85 | $5,665 | $67 |
| Digoxin | 84 | $3,616 | $43 |
| Digox | 46 | $2,479 | $54 |
| Eplerenone | 13 | $2,306 | $177 |
| Carvedilol | 222 | $2,160 | $10 |
| Atorvastatin | 79 | $1,918 | $24 |
| Potassium Chloride | 67 | $1,879 | $28 |
| Metoprolol | 159 | $1,578 | $10 |
| Mexiletine | 19 | $1,414 | $74 |
| Lisinopril | 151 | $1,094 | $7 |
| Chlorthalidone | 27 | $1,027 | $38 |
| Losartan | 68 | $1,013 | $15 |
| Cartia Xt | 15 | $910 | $61 |
| Pravastatin | 24 | $739 | $31 |
| Enoxaparin | 21 | $680 | $32 |
| Amiodarone | 30 | $638 | $21 |
| Valsartan | 11 | $467 | $42 |
| Amlodipine Besylate | 84 | $460 | $5 |
| Furosemide | 85 | $423 | $5 |
| Spironolactone | 52 | $419 | $8 |
| Doxycycline Hyclate | 12 | $288 | $24 |
| Triamterene-Hydrochlorothiazid | 24 | $278 | $12 |
| Hydralazine | 20 | $253 | $13 |
| Simvastatin | 22 | $218 | $10 |
| Warfarin | 24 | $212 | $9 |
| Pantoprazole | 18 | $184 | $10 |
| Lovastatin | 20 | $130 | $6 |
| Atenolol | 17 | $81 | $5 |
2014: 42 drugs
| Xarelto | 101 | $43,241 | $428 |
| Tikosyn | 71 | $27,806 | $392 |
| Pradaxa | 50 | $17,565 | $351 |
| Multaq | 27 | $13,842 | $513 |
| Flecainide Acetate | 134 | $7,112 | $53 |
| Metoprolol | 126 | $6,638 | $53 |
| Eliquis | 17 | $6,210 | $365 |
| Crestor | 11 | $4,608 | $419 |
| Niacin Er | 12 | $4,450 | $371 |
| Digoxin | 57 | $3,396 | $60 |
| Sotalol | 142 | $3,077 | $22 |
| Carvedilol | 253 | $2,482 | $10 |
| Digox | 40 | $2,429 | $61 |
| Atorvastatin | 90 | $2,202 | $24 |
| Potassium Chloride | 52 | $1,872 | $36 |
| Metoprolol | 197 | $1,603 | $8 |
| Lisinopril | 153 | $1,067 | $7 |
| Enoxaparin | 19 | $1,019 | $54 |
| Doxycycline Hyclate | 20 | $933 | $47 |
| Diltiazem 24hr Er | 16 | $919 | $57 |
| Diltiazem 24hr Cd | 28 | $732 | $26 |
| Pravastatin | 22 | $704 | $32 |
| Amiodarone | 27 | $652 | $24 |
| Losartan | 43 | $593 | $14 |
| Warfarin | 38 | $499 | $13 |
| Mexiletine | 12 | $490 | $41 |
| Spironolactone | 53 | $451 | $9 |
| Chlorthalidone | 27 | $428 | $16 |
| Amlodipine Besylate | 66 | $401 | $6 |
| Hydralazine | 18 | $391 | $22 |
| Furosemide | 84 | $387 | $5 |
| Clopidogrel | 12 | $354 | $29 |
| Metolazone | 11 | $317 | $29 |
| Nadolol | 12 | $314 | $26 |
| Simvastatin | 23 | $249 | $11 |
| Enalapril Maleate | 13 | $237 | $18 |
| Pantoprazole | 15 | $181 | $12 |
| Triamterene-Hydrochlorothiazid | 15 | $178 | $12 |
| Lovastatin | 17 | $120 | $7 |
| Metformin | 15 | $113 | $8 |
| Hydrochlorothiazide | 11 | $69 | $6 |
| Atenolol | 15 | $58 | $4 |
2013: 32 drugs
| Xarelto | 73 | $20,957 | $287 |
| Tikosyn | 27 | $8,851 | $328 |
| Pradaxa | 16 | $6,139 | $384 |
| Multaq | 18 | $5,511 | $306 |
| Propafenone | 21 | $4,752 | $226 |
| Metoprolol | 99 | $4,028 | $41 |
| Flecainide Acetate | 91 | $3,400 | $37 |
| Atorvastatin | 112 | $2,628 | $23 |
| Carvedilol | 244 | $2,542 | $10 |
| Diltiazem 24hr Er | 23 | $2,057 | $89 |
| Sotalol | 52 | $1,608 | $31 |
| Losartan | 56 | $1,576 | $28 |
| Potassium Chloride | 29 | $867 | $30 |
| Metoprolol | 105 | $779 | $7 |
| Lisinopril | 126 | $759 | $6 |
| Chlorthalidone | 27 | $492 | $18 |
| Clopidogrel | 14 | $435 | $31 |
| Amlodipine Besylate | 69 | $416 | $6 |
| Pravastatin | 25 | $403 | $16 |
| Spironolactone | 53 | $368 | $7 |
| Warfarin | 39 | $328 | $8 |
| Digox | 24 | $258 | $11 |
| Isosorbide Mononitrate Er | 16 | $242 | $15 |
| Amiodarone | 20 | $240 | $12 |
| Hydralazine | 11 | $230 | $21 |
| Simvastatin | 17 | $210 | $12 |
| Digoxin | 22 | $167 | $8 |
| Furosemide | 28 | $148 | $5 |
| Lovastatin | 12 | $122 | $10 |
| Verapamil | 11 | $88 | $8 |
| Atenolol | 12 | $75 | $6 |
| Hydrochlorothiazide | 14 | $62 | $4 |
Money from drug and device companies
$704 in 2025
| 2025 | 4 | 13 | None | $704 |
| 2024 | 7 | 50 | None | $6,771 |
| 2023 | 4 | 29 | $6,500 | $9,298 |
| 2022 | 6 | 13 | $8,400 | $8,996 |
| 2021 | 4 | 13 | None | $387 |
| 2020 | 3 | 8 | None | $222 |
| 2019 | 6 | 30 | None | $2,147 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biosense Webster | Carto 3 | $228 | 2 payments
|
| Boston Scientific | Watchman Flx | $170 | 6 payments
|
| Abbott Laboratories | Triclip | $169 | 1 payment
|
| Medtronic | Micra | $137 | 4 payments
|
See all 13 published payments
| Boston Scientific | Meals · 2025-11-18 | General - Brady | $10 |
| Boston Scientific | Meals · 2025-11-18 | General - Brady | $11 |
| Boston Scientific | Meals · 2025-09-24 | Lux-Dx Insertable Cardiac Monitor | $14 |
| Boston Scientific | Meals · 2025-09-24 | Lux-Dx Insertable Cardiac Monitor | $15 |
| Boston Scientific | Meals · 2025-07-30 | Lux-Dx Insertable Cardiac Monitor | $9 |
| Abbott Laboratories | Meals · 2025-06-09 | Triclip | $169 |
| Biosense Webster | Meals · 2025-06-03 | Carto 3 | $109 |
| Medtronic | Meals · 2025-04-24 | Plasmablade(Tm) | $44 |
| Medtronic | Meals · 2025-04-10 | Micra | $24 |
| Medtronic | Meals · 2025-03-14 | Micra | $50 |
| Biosense Webster | Meals · 2025-03-06 | Carto 3 | $118 |
| Boston Scientific | Meals · 2025-02-12 | Watchman Flx | $110 |
| Medtronic | Meals · 2025-01-13 | Symplicity G3 | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $6,771
| Medtronic | Micra | $4,884 | 29 payments
|
| Boston Scientific | Ingevity+ | $1,317 | 10 payments
|
| Abbott Laboratories | Aveir | $316 | 4 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $118 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $88 | 4 payments
|
| Lantheus Medical Imaging | Definity | $27 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
2023: $9,298
| Acutus Medical | None | $6,500 | 1 payment
|
| Medtronic | None | $2,390 | 22 payments
|
| Abbott Laboratories | Aveir | $390 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $18 | 1 payment
|
2022: $8,996
| Galvanize Therapeutics | Aliya System | $8,400 | 2 payments
|
| Abbott Laboratories | Confirm Rx | $150 | 1 payment
|
| Medtronic | Micra | $125 | 1 payment
|
| Biosense Webster | None | $120 | 1 payment
|
| Boston Scientific | Rhythmia Mapping System | $109 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $92 | 6 payments
|
2021: $387
| Biotronik | Solia | $128 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $113 | 7 payments
|
| Acutus Medical | None | $107 | 4 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $40 | 1 payment
|
2020: $222
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $114 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $71 | 5 payments
|
| Biosense Webster | Carto 3 System | $37 | 1 payment
|
2019: $2,147
| Medtronic Vascular | Carelink | $1,081 | 9 payments
|
| Biosense Webster | Carto 3 System | $444 | 9 payments
|
| Boston Scientific | General Ep | $317 | 8 payments
|
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $144 | 2 payments
|
| Medical Device Business Services | Carto 3 System | $129 | 1 payment
|
| Acist Medical Systems | Cvi Consumables | $33 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| AstraZeneca Pharmaceuticals LP · A Phase 2a Randomized Double Blind Placebo-Controlled Study To Evaluate the Efficacy and Safety of Medi3506 in Subjects With Diabetic Kidney Disease · 2020 | Their institution | $9,935 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376620294
- Licence
- CA A108412, NV 14603California A108412: Current · expires 2027-05-31
- Trained
- Wayne State University School of Medicine, 2003
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NV 1376620294
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-11-01
- NPI last updated
- 2024-04-20
- NPI record certified
- 2024-04-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3801 Miranda Ave Ste 111c, Palo Alto, CA, 94304 · 1500 E 2nd St, Reno, NV, 89502